Login to Your Account

Pharma: Clinic roundup

Thursday, May 15, 2014
Astellas Pharma US Inc., of Northbrook, Ill., part of Astellas Pharma Inc., reported that efficacy and safety data of the isavuconazole invasive aspergillosis study (SECURE) were presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Barcelona, Spain.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription